NVDA

110.51

+0.43%↑

AVGO.US

172.47

+2.42%↑

ORCL

145.97

+2.82%↑

CRM

272.1

+0.73%↑

CSCO

61.84

+0.15%↑

NVDA

110.51

+0.43%↑

AVGO.US

172.47

+2.42%↑

ORCL

145.97

+2.82%↑

CRM

272.1

+0.73%↑

CSCO

61.84

+0.15%↑

NVDA

110.51

+0.43%↑

AVGO.US

172.47

+2.42%↑

ORCL

145.97

+2.82%↑

CRM

272.1

+0.73%↑

CSCO

61.84

+0.15%↑

NVDA

110.51

+0.43%↑

AVGO.US

172.47

+2.42%↑

ORCL

145.97

+2.82%↑

CRM

272.1

+0.73%↑

CSCO

61.84

+0.15%↑

NVDA

110.51

+0.43%↑

AVGO.US

172.47

+2.42%↑

ORCL

145.97

+2.82%↑

CRM

272.1

+0.73%↑

CSCO

61.84

+0.15%↑

Search

Genpact Ltd

Gesloten

SectorTechnologie

50.54 -0.04

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

49.76

Max

50.63

Belangrijke statistieken

By Trading Economics

Inkomsten

9.1M

142M

Verkoop

38M

1.2B

K/W

Sectorgemiddelde

17.677

96.228

EPS

0.91

Dividendrendement

1.35

Winstmarge

11.365

Werknemers

140,000

EBITDA

22M

228M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+15.82% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.35%

2.26%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

348M

8.9B

Vorige openingsprijs

50.58

Vorige sluitingsprijs

50.54

Nieuwssentiment

By Acuity

12%

88%

24 / 412 Rangschikking in Technology

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

Genpact Ltd Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

13 mrt 2025, 06:45 UTC

Winsten

Generali Operating Profit Rises on Higher Premiums

3 feb 2025, 07:06 UTC

Acquisities, Fusies, Overnames

UniCredit Says It Holds 4.1% Stake in Generali

30 jan 2025, 11:40 UTC

Acquisities, Fusies, Overnames

Generali Guides for Faster Earnings Growth, Higher Shareholder Returns -- Update

1 apr 2025, 13:31 UTC

Top Nieuws
Acquisities, Fusies, Overnames

European Insurers Will Be Slower Than Banks to Consolidate, Generali Executive Says -- Interview

1 apr 2025, 13:31 UTC

Acquisities, Fusies, Overnames

Trends in European Insurance Are Fundamentally Positive, Consumer Demand Is Strong, Terzariol Says

1 apr 2025, 13:31 UTC

Acquisities, Fusies, Overnames

Smaller Insurance Players Might Become M&A Targets if Conditions Become Challenging, Terzariol Says

1 apr 2025, 13:30 UTC

Acquisities, Fusies, Overnames

Fewer European Insurers Will Be Around in 10, 20 Years, Generali's Terzariol Says

1 apr 2025, 13:30 UTC

Acquisities, Fusies, Overnames

European Insurers to Consolidate at Gradual Pace, Generali's Insurance Chief Says

1 apr 2025, 08:09 UTC

Marktinformatie

Generali's Board Tussle Is Main Risk for Shares -- Market Talk

1 apr 2025, 07:52 UTC

Marktinformatie
Winsten

European Insurers Liked by North American Investors -- Market Talk

31 mrt 2025, 08:09 UTC

Marktinformatie

Mediobanca's List for Generali's Board Likely to Be Supported, Equita Says -- Market Talk

13 mrt 2025, 08:00 UTC

Marktinformatie
Winsten

Generali's Dividend Growth Stands Out -- Market Talk

13 mrt 2025, 07:57 UTC

Marktinformatie
Winsten

Generali's Results Look Solid -- Market Talk

13 mrt 2025, 06:07 UTC

Winsten

Generali Backs 2025-27 Targets

13 mrt 2025, 06:05 UTC

Winsten

Generali End 2024 AUM EUR863B

13 mrt 2025, 06:04 UTC

Winsten

Analysts Saw Generali 2024 Dividend EUR1.40

13 mrt 2025, 06:04 UTC

Winsten

Generali Proposes EUR1.43 Dividend Per Share

13 mrt 2025, 06:04 UTC

Winsten

Generali 2024 New Business Margin 4.60%

13 mrt 2025, 06:04 UTC

Winsten

Analysts Saw Generali End 2024 Solvency Ratio 211%

13 mrt 2025, 06:04 UTC

Winsten

Generali End 2024 Solvency Ratio 210%

13 mrt 2025, 06:04 UTC

Winsten

Analysts Saw Generali 2024 Combined Ratio 94.0%

13 mrt 2025, 06:04 UTC

Winsten

Generali 2024 Combined Ratio 94.0%

13 mrt 2025, 06:03 UTC

Winsten

Analysts Saw Generali 2024 Oper Result EUR7.23B

13 mrt 2025, 06:03 UTC

Winsten

Generali 2024 Oper Pft EUR7.295B

13 mrt 2025, 06:03 UTC

Winsten

Analysts Saw Generali 2024 Gross Written Premiums EUR94.21B

13 mrt 2025, 06:03 UTC

Winsten

Generali 2024 Gross Written Premiums EUR95.19B

13 mrt 2025, 06:03 UTC

Winsten

Analysts Saw Generali 2024 Adj. Net Pft EUR3.76B

13 mrt 2025, 06:03 UTC

Winsten

Generali 2024 Adj. Net Pft EUR3.77B

13 mrt 2025, 06:03 UTC

Winsten

Analysts Saw Generali 2024 Net Pft EUR3.825B

13 mrt 2025, 06:03 UTC

Winsten

Generali 2024 Net Pft EUR3.72B

Peer Vergelijking

Prijswijziging

Genpact Ltd Prognose

Koersdoel

By TipRanks

15.82% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 58.56 USD  15.82%

Hoogste 65 USD

Laagste 55 USD

Gebaseerd op 9 Wall Street-analisten die 12-maands prijsdoelen bieden voor Genpact Ltd - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

9 ratings

4

Buy

5

Hold

0

Sell

Technische score

By Trading Central

4.97 / 5.02Steun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Weak Bearish Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

24 / 412 Rangschikking in Technologie

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Genpact Ltd

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims. The Consumer and Healthcare segment provides demand generation, sensing and planning, supply chain planning and management, pricing and trade promotion management, deduction recovery management, order management, and digital commerce; and end-to-end claim lifecycle management, from claims processing and adjudication to claims recovery and payment integrity, revenue cycle management, health equity analytics, and care services. The High Tech and Manufacturing segment offers industry-specific solutions for trust and safety, advertising sales support, customer and user experience, and customer care support; and direct and indirect procurement, logistics, field, aftermarket support, and engineering services. It also provides digital operation services; data-tech-Al services; finance and accounting services, such as accounts payable, invoice-to-cash, record to report, financial planning and analysis, and enterprise risk and compliance; CFO advisory services; supply chain, and sourcing and procurement services; sales and commercial, and marketing and experience services; and environmental, social and governance services. The company was founded in 1997 and is based in Hamilton, Bermuda.